Post by account_disabled on Feb 28, 2024 3:33:46 GMT -5
Stock gurus point out that EKH has benefited positively from COVID-19. Push the number of screening tests up / out-patients and in-patients continue to increase Increase profit target for 2020 by 50% The broker recommends "buy" shares of Ekachai Medical Public Company Limited (EKH), pointing out support from COVID-19 screening, plus the RSV virus that is spreading heavily among young children helps support. Meanwhile, inpatients and outpatients continue to access services. Adjusted the net profit target for 2020, increasing 50% to 52 million baht, while net profit for 2021 increased 4% to 96 million baht, indicating the base price target at 6 baht. KTBST Securities Public Company Limited has published an analysis of Ekachai Medical Company Limited (EKH) which expects that EKH will have revenue from COVID-19 screening of approximately 20 million baht, or 3%.
of total revenue for the year 2020, with the research department assuming Portugal Phone Number that there will be 500 cases/day screening, representing 11 days from 20-31 December 2020. The cost of the examination is 4,150 baht/case, which at present the company There is capacity to support COVID-19 screening (Lab) for approximately 1,000 cases/day, with people still coming in for screening continuously. In addition, currently the rate of inpatients using the service (IPD Utilization rate) has skyrocketed to 70% from 40% in the 3rd quarter of 2020 as a result of the RSV virus that is spreading heavily among young children. Even though the current COVID-19 outbreak situation In Samut Sakhon Province It will still look worrisome. But the number of infected people has begun to decrease. In addition, people in the area are more confident in the safety of using services at the hospital. As a result, inpatients and outpatients did not decrease as significantly as in the second quarter of 2020.
Meanwhile, the IVF situation is gradually improving. At present, there are approximately 3-4 cases of Thai people using the service and approximately 10 cases of Chinese people, an improvement from the 2-3rd quarter of 2020 when there were no people using the service at all. In this regard, the research department has adjusted net profit for 2020 to increase by 50% to 52 million baht and adjusted net profit for 2021 by 4% to 96 million baht. The main factors come from 1. Adjusted Gross Profit Margin for 2020 by 200 bps to 27% from Previously at 25% and in 2021 increased 300 bps to 33% from the original 30%. Currently, IPD Utilization rate in 4Q20 has recovered better than what the research department expected to be 70% (Q3/2020=40%, 2Q/2020= 30%), benefiting from the RSV outbreak in young children, including income from COVID-19 screening. It is assumed that there will be 500 cases/day for screening for 11 days.
of total revenue for the year 2020, with the research department assuming Portugal Phone Number that there will be 500 cases/day screening, representing 11 days from 20-31 December 2020. The cost of the examination is 4,150 baht/case, which at present the company There is capacity to support COVID-19 screening (Lab) for approximately 1,000 cases/day, with people still coming in for screening continuously. In addition, currently the rate of inpatients using the service (IPD Utilization rate) has skyrocketed to 70% from 40% in the 3rd quarter of 2020 as a result of the RSV virus that is spreading heavily among young children. Even though the current COVID-19 outbreak situation In Samut Sakhon Province It will still look worrisome. But the number of infected people has begun to decrease. In addition, people in the area are more confident in the safety of using services at the hospital. As a result, inpatients and outpatients did not decrease as significantly as in the second quarter of 2020.
Meanwhile, the IVF situation is gradually improving. At present, there are approximately 3-4 cases of Thai people using the service and approximately 10 cases of Chinese people, an improvement from the 2-3rd quarter of 2020 when there were no people using the service at all. In this regard, the research department has adjusted net profit for 2020 to increase by 50% to 52 million baht and adjusted net profit for 2021 by 4% to 96 million baht. The main factors come from 1. Adjusted Gross Profit Margin for 2020 by 200 bps to 27% from Previously at 25% and in 2021 increased 300 bps to 33% from the original 30%. Currently, IPD Utilization rate in 4Q20 has recovered better than what the research department expected to be 70% (Q3/2020=40%, 2Q/2020= 30%), benefiting from the RSV outbreak in young children, including income from COVID-19 screening. It is assumed that there will be 500 cases/day for screening for 11 days.